CNR Institutional Research Information System

SARTORIUS, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.519
NA - Nord America 1.084
EU - Europa 388
SA - Sud America 317
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 25
OC - Oceania 6
Totale 3.427
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.015
SG - Singapore 575
CN - Cina 349
BR - Brasile 248
HK - Hong Kong 160
VN - Vietnam 147
IT - Italia 113
FR - Francia 72
KR - Corea 69
JP - Giappone 51
DE - Germania 47
BD - Bangladesh 36
IN - India 35
GB - Regno Unito 33
FI - Finlandia 32
CA - Canada 27
NL - Olanda 26
AR - Argentina 25
MX - Messico 15
CO - Colombia 14
ID - Indonesia 13
EC - Ecuador 10
PK - Pakistan 10
PL - Polonia 10
ZA - Sudafrica 9
IL - Israele 8
IQ - Iraq 8
RU - Federazione Russa 7
SA - Arabia Saudita 7
SE - Svezia 7
AU - Australia 6
PH - Filippine 6
TR - Turchia 6
CR - Costa Rica 5
PY - Paraguay 5
UZ - Uzbekistan 5
ES - Italia 4
JM - Giamaica 4
KE - Kenya 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
IE - Irlanda 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PA - Panama 3
PT - Portogallo 3
TH - Thailandia 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UA - Ucraina 3
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
HN - Honduras 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
VC - Saint Vincent e Grenadine 1
VG - Isole Vergini Britanniche 1
Totale 3.339
Salva come PNG Salva come JPEG
Città #
Singapore 345
Santa Clara 206
Hong Kong 159
San Jose 148
Hefei 131
Beijing 72
Ashburn 71
Seoul 68
Los Angeles 52
Ho Chi Minh City 48
Lauterbourg 45
Tokyo 42
Dallas 41
Hanoi 35
New York 30
Marigliano 26
Helsinki 22
Rome 21
Frankfurt am Main 20
São Paulo 19
Orem 16
Buffalo 14
Council Bluffs 13
Naples 12
Rio de Janeiro 11
Falkenstein 10
Chicago 9
Houston 9
Lappeenranta 9
Brasília 8
Chennai 8
Da Nang 8
Amsterdam 7
Atlanta 7
Avellino 7
Bogotá 7
Brooklyn 7
Denver 7
Minamishinagawa 7
Ninh Bình 7
Warsaw 7
Bengaluru 6
Boardman 6
Dhaka 6
Düsseldorf 6
London 6
Montreal 6
Nuremberg 6
Phoenix 6
Stockholm 6
Haiphong 5
Manchester 5
Miami 5
Portsmouth 5
Salvador 5
Tashkent 5
Ankara 4
Biên Hòa 4
Fort Worth 4
Guarulhos 4
Johannesburg 4
Karachi 4
Lexington 4
Mexico City 4
Montevideo 4
Nairobi 4
Quito 4
San José 4
Santo André 4
Sydney 4
Washington 4
Araçatuba 3
Asunción 3
Baghdad 3
Bandung 3
Belo Horizonte 3
Bexley 3
Bologna 3
Boston 3
Buenos Aires 3
Calgary 3
Dushanbe 3
Elk Grove Village 3
Goiânia 3
Jackson 3
Jakarta 3
Kingston 3
Kunming 3
Lahore 3
Lisbon 3
New Orleans 3
Peoria 3
Praia Grande 3
Santiago 3
The Bronx 3
Toronto 3
Vancouver 3
Addis Ababa 2
Ahmedabad 2
Albany 2
Totale 2.019
Salva come PNG Salva come JPEG
Nome #
Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell. 118
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 117
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy 97
Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation 95
Give a selfie for women @CNR 81
300x100: Protagoniste per la ricerca 79
Immunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the marine diatom Thalassiosira weissflogii: Inspiration for a novel synthetic toll-like receptor 4 agonist 78
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants 75
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants. 74
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking 71
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 70
Engineering and Development of a Tissue Model for the Evaluation of Microneedle Penetration Ability, Drug Diffusion, Photothermal Activity, and Ultrasound Imaging: A Promising Surrogate to Ex Vivo and In Vivo Tissues 69
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 63
An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy 59
Arming filamentous bacteriophage, aNature-made nanoparticles, for new vaccine and immunotherapeutic strategies 59
Chitosan decorated cobalt zinc ferrite nanoferrofluid composites for potential cancer hyperthermia therapy: anti-cancer activity, genotoxicity, and immunotoxicity evaluation 58
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 58
PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based vaccine: in vitro and in silico-supported approach 57
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies 57
Searching for new vaccine vectors: E2 protein from B. stearothermophilus PDH complex. 56
Bioengineered materials with selective antimicrobial toxicity in biomedicine 55
Recombinant filamentous bacteriophages encapsulated in biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses 55
PHAGE CONJUGATES AND USES THEREOF 54
ImmuNapoli 2019 54
Non-spherical nanostructures in nanomedicine: From noble metal nanorods to transition metal dichalcogenide nanosheets 54
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 52
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 50
Cell loaded hydrogel containing Ag-doped bioactive glass-ceramic nanoparticles as skin substitute: Antibacterial properties, immune response, and scarless cutaneous wound regeneration 49
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 49
E2 multimeric scaffold for vaccine formulation: transcriptome analysis of pulsed dendritic cells and immune response by intranasal delivery. 47
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 46
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside 46
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 45
Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers 45
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 44
Nonspherical Metal-Based Nanoarchitectures: Synthesis and Impact of Size, Shape, and Composition on Their Biological Activity 44
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 43
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses 43
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 42
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. 42
Filamentous bacteriophage: an antigen and gene delivery system 41
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFN³ production by CD4+ T cells 40
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 40
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 37
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 36
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. 36
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 36
New recombinant vaccine based on filamentous bacteriophage fd particles targeting DC 35
Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR 9 Expression 35
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. 35
Antigen delivery by using filamentous bacteriophage FD or a macromolecular scaffold derived from a multienzyme complex 35
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 34
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 34
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 34
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo 34
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 33
Comparative analysis of innovative vaccine formulations based on the use of procaryotic display systems. 32
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 32
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 32
ImmuNapoli 2016 31
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 31
Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex. 30
Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses 30
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 29
Cellular and molecular mechanisms of vaccination by bacteriophages. 29
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. 26
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 23
null 20
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo. 19
null 14
null 12
null 12
Totale 3.427
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.339
article - articoli 7.427
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 245
Totale 19.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202442 0 0 0 0 0 0 0 1 0 2 34 5
2024/20251.156 1 4 88 28 193 35 9 169 44 46 289 250
2025/20261.882 98 148 197 317 315 112 234 75 109 141 83 53
2026/2027347 86 66 195 0 0 0 0 0 0 0 0 0
Totale 3.427